International Journal of Radiation Oncology * Biology * Physics
Volume 65, Issue 5 , Pages 1307-1314 , 1 August 2006

18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinoma

This article was presented at the Forty-Seventh Annual Meeting of the American Society for Therapeutic Radiology and Oncology, October 16–20, 2005, Denver, CO.

  • Tzu-Chen Yen, M.D., Ph.D.

      Affiliations

    • Molecular Imaging Center, Taipei Chang Gung Head and Neck Oncology Group, Chang Gung Memorial Hospital–Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
    • ,
  • Chien-Yu Lin, M.D.

      Affiliations

    • Department of Nuclear Medicine, Taipei Chang Gung Head and Neck Oncology Group, Chang Gung Memorial Hospital–Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
    • ,
  • Hung-Ming Wang, M.D.

      Affiliations

    • Department of Radiation Oncology, Taipei Chang Gung Head and Neck Oncology Group, Chang Gung Memorial Hospital–Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
    • ,
  • Shiang-Fu Huang, M.D.

      Affiliations

    • Department of Medical Oncology, Taipei Chang Gung Head and Neck Oncology Group, Chang Gung Memorial Hospital–Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
    • ,
  • Chun-Ta Liao, M.D.

      Affiliations

    • Department of Medical Oncology, Taipei Chang Gung Head and Neck Oncology Group, Chang Gung Memorial Hospital–Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
    • ,
  • Chung-Jan Kang, M.D.

      Affiliations

    • Department of Medical Oncology, Taipei Chang Gung Head and Neck Oncology Group, Chang Gung Memorial Hospital–Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
    • ,
  • Shu-Hang Ng, M.D.

      Affiliations

    • Department of Otorhinolaryngology, Taipei Chang Gung Head and Neck Oncology Group, Chang Gung Memorial Hospital–Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
    • ,
  • Sheng-Chieh Chan, M.D.

      Affiliations

    • Molecular Imaging Center, Taipei Chang Gung Head and Neck Oncology Group, Chang Gung Memorial Hospital–Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
    • ,
  • Kang-Hsing Fan, M.D.

      Affiliations

    • Department of Nuclear Medicine, Taipei Chang Gung Head and Neck Oncology Group, Chang Gung Memorial Hospital–Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
    • ,
  • I.-How Chen, M.D.

      Affiliations

    • Department of Medical Oncology, Taipei Chang Gung Head and Neck Oncology Group, Chang Gung Memorial Hospital–Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
    • ,
  • Wuu-Jyh Lin, Ph.D.

      Affiliations

    • Institute of Nuclear Energy Research, Taoyuan, Taiwan
    • ,
  • Ann-Joy Cheng, Ph.D.

      Affiliations

    • Department of Medical Biotechnology, Taipei Chang Gung Head and Neck Oncology Group, Chang Gung Memorial Hospital–Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
    • ,
  • Joseph Tung-Chieh Chang, M.D., M.H.A.

      Affiliations

    • Department of Nuclear Medicine, Taipei Chang Gung Head and Neck Oncology Group, Chang Gung Memorial Hospital–Linkou Medical Center, Chang Gung University, Taoyuan, Taiwan
    • Corresponding Author InformationReprint requests to: Joseph Tung-Chieh Chang, M.D., M.H.A., Department of Radiation Oncology, Chang Gung Memorial University Hospital, Linkou Medical Center, 5 Fu-Shin St, Kueishan, Taoyuan 333, Taiwan. Tel: (+886) 3-3281200 ext. 2613; Fax: (+886) 3-3280797

Received 9 November 2005 ,Revised 22 February 2006 ,Accepted 22 February 2006.

References 

  1. Huang DP . Epidemiology and aetiology . In:  Hasselt CAV ,  Gibb AG editor. Nasopharyngeal carcinoma . Hong Kong: The Chinese University Press; 1991;p. 23–44
  2. Easton JM , Levine PH , Hyams VJ . Nasopharyngeal carcinoma in the United States (A pathological study of 177 US and 30 foreign cases) . Arch Otolaryngol . 1980;106:88–91
  3. Choo R , Tannock I . Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx (A review of the Princess Margaret Hospital experience) . Cancer . 1991;68:2120–2124
  4. Gebbia V , Zerillo G , Restivo G , et al.   Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma (A retrospective analysis of 40 cases) . Br J Cancer . 1993;68:191–194
  5. Chang JT , See LC , Liao CT , et al.   Locally recurrent nasopharyngeal carcinoma . Radiother Oncol . 2000;54:135–142
  6. Chang KP , Hao SP , Tsang NM , Ueng SH . Salvage surgery for locally recurrent nasopharyngeal carcinoma (A 10-year experience) . Otolaryngol Head Neck Surg . 2004;131:497–502
  7. Chang JT , Chen LH , Tang SG , et al.   Acute toxicities and feasibility of altered fractionated radiotherapy in nasopharyngeal carcinoma . Chang Gung Med J . 1997;20:107–114
  8. Le QT , Tate D , Koong A , et al.   Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma . Int J Radiat Oncol Biol Phys . 2003;56:1046–1054
  9. Lee AWM , Law SCK , Foo W , et al.   Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985 (Survival after local recurrence) . Int J Radiat Oncol Biol Phys . 1993;26:773–782
  10. Vikram B , Hilaris B . Transnasal permanent interstitial implantation for carcinoma of the nasopharynx . Int J Radiat Oncol Biol Phys . 1984;10:153–155
  11. Choy D , Sham JS , Wei WI , Ho CM , Wu FM . Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma . Int J Radiat Oncol Biol Phys . 1993;25:505–512
  12. Park JO , Lee SI , Song SY , et al.   Measuring response in solid tumors (Comparison of RECIST and WHO response criteria) . Jap J Clin Oncol . 2003;33:533–537
  13. Prasad SR , Saini S , Sumner JE , Hahn PF , Sahani D , Boland GW . Radiological measurement of breast cancer metastases to lung and liver (Comparison between WHO (bidimensional) and RECIST (unidimensional) guidelines) . J Comput Assist Tomogr . 2003;27:380–384
  14. Chong VFH , Fan YF . Detection of recurrent nasopharyngeal carcinoma (MR imaging versus CT) . Radiology . 1997;202:463–470
  15. Olmi P , Fallai C , Colagradne S , Giannardi G . Staging and follow up of nasopharyngeal carcinoma (Magnetic resonance imaging versus computerized tomography) . Int J Radiat Oncol Biol Phys . 1995;32:795–800
  16. Gong QY , Zheng GL , Zhu HY . MRI differentiation of recurrent nasopharyngeal carcinoma from postradiation fibrosis . Comput Med Imaging Graph . 1991;15:423–429
  17. Ng SH , Chang TC , Ko SF , Wan YL , Tang LM , Chen WC . MRI in recurrent nasopharyngeal carcinoma . Neuroradiology . 1999;41:855–862
  18. Ng SH , Wan YL , Ko SF , Chang JT . MRI of nasopharyngeal carcinoma with emphasis on relationship to radiotherapy . J Magn Reson Imaging . 1998;8:327–336
  19. Kostakoglu L , Goldsmith SJ . 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma . J Nucl Med . 2003;44:224–239
  20. Grigsby PW , Siegel BA , Dehdashti F , Rader J , Zoberi I . Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix (Response and outcome) . J Clin Oncol . 2004;22:2167–2171
  21. Swisher SG , Erasmus J , Maish M , et al.   2-fluoro-2-deoxy-d-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma . Cancer . 2004;101:1776–1785
  22. Vansteenkiste J , Fischer BM , Dooms C , Mortensen J . Positron-emission tomography in prognostic and therapeutic assessment of lung cancer (Systemic review) . Lancet Oncol . 2004;5:531–540
  23. Ng SH , Chang JCT , Chan SC , et al.   Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence . J Nucl Med . 2004;45:1669–1676
  24. Lin JC , Jan JS , Hsu CY , Liang WM , Jiang RS , Wang WY . Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma (Positive effect on overall and progression-free survival) . J Clin Oncol . 2003;21:631–637
  25. Hicks RJ , Mac Manus MP , Matthews JP , et al.   Early FDG-PET imaging after radical radiotherapy for non–small-cell lung cancer (Inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation) . Int J Radiat Oncol Biol Phys . 2004;60:412–418
  26. Fleming ID , Cooper JS , Henson DE , et al.   In: AJCC Cancer staging manual . 6th ed.. Philadelphia: Lippincott Williams & Wilkins; 2002;p. 35
  27. Yen TC , Ng KK , Ma SY , et al.   Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer . J Clin Oncol . 2003;21:3651–3658
  28. Minn H , Joensuu H , Ahonen A , Klemi P . Fluorodeoxyglucose imaging (A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors) . Cancer . 1988;61:1766–1781
  29. Guillem JG , Moore HG , Akhurst T , et al.   Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation (A means for determining longterm outcomes of rectal cancer) . J Am Coll Surg . 2004;199:1–7
  30. Kitagawa Y , Sadato N , Azuna H , et al.   FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms . J Nucl Med . 1999;40:1132–1137
  31. Kitagawa Y , Sano K , Nishizawa S , et al.   FDG-PET for prediction of tumor aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer . Eur J Nucl Med Mol Imaging . 2003;30:63–71
  32. Halfpenny W , Hain SF , Biassoni L , et al.   FDG-PET (A possible prognostic factor in head and neck cancer) . Br J Cancer . 2002;86:512–516
  33. Allal AS , Dulguerov P , Allaoua M , et al.   Standardized uptake value of 2-[18F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy . J Clin Oncol . 2002;20:1398–1404
  34. Swisher SG , Erasmus J , Maish M , et al.   2-fluoro-2-deoxy-d-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma . Cancer . 2004;101:1776–1785
  35. Yao M , Graham MM , Hoffman HT , et al.   The role of post-radiation therapy FDG PET in prediction of necessity for postradiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma . Int J Radiat Oncol Biol Phys . 2004;59:1001–1010
  36. Kitagawa Y , Nishizawa S , Sano K , et al.   Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma . J Nucl Med . 2003;44:198–206
  37. Brucher BL , Weber W , Bauer M , et al.   Neoadjuvant therapy of esophageal squamous cell carcinoma (Response evaluation by positron emission tomography) . Ann Surg . 2001;233:300–309
  38. Rege SD , Chaiken L , Hoh CK , et al.   Change induced by radiation therapy in FDG uptake in normal and malignant structures of head and neck (Quantitation with PET) . Radiology . 1993;198:807–812
  39. Chaiken L , Rege S , Hoh C , et al.   Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy . Int J Radiat Oncol Biol Phys . 1993;27:455–464

 This research is supported by grants NSC 92-2314-B-182A-081 (Dr. Ng) from the National Science Council-Taiwan and CMRPG32034 (Dr. Yen) from the Chang Gung Memorial Hospital and University.

PII: S0360-3016(06)00388-9

doi: 10.1016/j.ijrobp.2006.02.031

International Journal of Radiation Oncology * Biology * Physics
Volume 65, Issue 5 , Pages 1307-1314 , 1 August 2006

Article Tools

* Image Usage & Resolution